We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App

TianLong Participated in the International Medical Congress of SCO Countries in Kyrgyzstan

By LabMedica International staff writers
Posted on 16 Apr 2024
Print article
TianLong Participated in the International Medical Congress of SCO Countries in Kyrgyzstan (photo courtesy of Tianlong)
TianLong Participated in the International Medical Congress of SCO Countries in Kyrgyzstan (photo courtesy of Tianlong)
The International Medical Congress of the SCO countries kicked off in Bishkek, Kyrgyzstan on March 27-29 under the topic “Innovations and technologies in the development of cardiology and non-communicable diseases in the countries of the Shanghai Cooperation Organization.” TianLong Science and Technology Co., Ltd. was invited to attend and deliver a speech at the Congress, showcasing and discussing its latest achievements and innovations in the fields of personalized medication and laboratory medicine with top experts.

Minister of Health of the Kyrgyz Republic Alymkadyr Beishenaliev, Deputy Secretary General of the SCO Janesh Kane, as well as 400 medical staff and representatives of medical organizations, including more than 100 foreign guests, academicians and world-famous scientists, took part in the Congress, dedicated to the memory of the outstanding scientist and clinician, academician Mirsaid Mirrakhimov.

At this Congress, Tianlong invited Professor Kou Huijuan from the Department of Cardiology at the Second Affiliated Hospital of Xi'an Jiaotong University to deliver a speech. During the speech, Professor Kou discussed the precise treatment and current progress of hypertension diagnosis and treatment in China, as well as a series of clinical cases. Professor Kou also shared Tianlong's personalized medication solution of hypertension, which can detect seven gene mutations in hypertension medication and guide five types of hypertension medication. She introduced that “Personalized medication is a new medical model that can determine the dosage and type of drugs for each patient based on genetic differences. We have developed from general therapy to individualized medication”, which has brought valuable inspiration to the attendees.

Tianlong was also invited to join in a series of conferences and exchanges in Kyrgyzstan. At an international conference on “Topical issues of laboratory medicine”, Jessica Wu(PhD of Molecular Biology) from Tianlong’s Overseas Marketing Dept, delivered a speech about “LigSeq Reagent Kit - Tianlong's personalized medication solutions”. During the presentation, Dr. Wu discussed the significance of personalized medication and shared the latest research and application cases. She introduced that “Tianlong's personalized medication solution can detect genes related to the effects of commonly used drugs for diseases, providing guidance for clinical treatment.” The presentation has generated widespread interest and discussion among the attending experts.

In addition, Professor Kou and Dr. Wu were invited to give lectures at the Sixth State Hospital in Bishkek, as well as at the local cardiac surgery clinic and medical centre. During the series of lectures, they shared the latest medical technologies and research on hypertension, and also engaged in technical exchanges, which were welcomed by the local medical staff and built a solid bridge for international exchange and cooperation.

LigSeq Reagent Kit
Tianlong Personalized Medication Solutions

Tianlong's personalized medication solutions, including a series of detection instrument and reagents, can detect genes related to the effects of commonly used drugs for assisted reproduction, endocrine drugs, as well as cardiovascular, digestive, psychiatric, rheumatic immunity, oncology and other diseases, providing guidance for clinical treatment.

It has the advantages of rapid detection, accurate results, comprehensive reports and user-friendly.

Through these medical conferences, Tianlong showcased its innovations and research achievements in laboratory medicine and personalized medication. The conferences also facilitated international exchanges and cooperation in the medical field. In the future, Tianlong will continue its commitment to scientific research, innovation, and technological development for the global advancement of medicine and healthcare.

For more information or inquiries, please contact Tianlong team directly.

Print article


Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The blood test uses AI to predict Parkinson’s seven years before onset of symptoms (Photo courtesy of Kateryna Kon/Shutterstock)

AI-Powered Blood Test Predicts Parkinson's Seven Years before Symptoms Appear

Parkinson’s disease is currently the fastest-growing neurodegenerative disorder worldwide, affecting nearly 10 million people globally. It is a progressive disease caused by the deterioration and death... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.